首页 › 基金 › Pivotal bioVenture Partners Investment Advisor LLC › MPLT
Pivotal bioVenture Partners Investment Advisor LLC 对 MPLT 的持仓历史
MAPLIGHT THERAPEUTICS INC · 医疗保健
Pivotal bioVenture Partners Investment Advisor LLC 在 Q3 2026 的 13F 申报中披露持有 MPLT(MAPLIGHT THERAPEUTICS INC)611,446 股,市值约 US$6.2M,约占其申报组合的 2.54%,在其申报持仓中市值排名第 11 位。 Pivotal bioVenture Partners Investment Advisor LLC 最近 4 个申报季度中有 4 个季度披露了 MPLT 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR
Pivotal bioVenture Partners Investment Advisor LLC 对 MPLT 的持仓演变
Pivotal bioVenture Partners Investment Advisor LLC 于 Q4 2025 首次披露 MPLT 持仓:611,447 股(约 US$10.7M)。 该持仓在 Q2 2026 达到峰值 611,446 股,市值约 US$21.9M。 在 4 次申报中,Pivotal bioVenture Partners Investment Advisor LLC 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 611,446 股、市值约 US$6.2M。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 611.45K | $10.74M | 新进 |
| Q1 2026 | 611.45K | $12.43M | 持有 |
| Q2 2026 | 611.45K | $21.91M | 持有 |
| Q3 2026 | 611.45K | $6.23M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 MPLT 与 13F 数据
MPLT(MAPLIGHT THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 97 只申报持有 MPLT,申报仓位最大的包括:Novo Holdings A/S (US$132.1M), FCPM III SERVICES B.V. (US$115.6M), 5AM Venture Management, LLC (US$34.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 MPLT 的基金
- Novo Holdings A/S 3.69M 股 · $132.13M · Q2 2026
- FCPM III SERVICES B.V. 3.23M 股 · $115.63M · Q2 2026
- 5AM Venture Management, LLC 950.01K 股 · $34.05M · Q2 2026
- Paradigm Biocapital Advisors LP 685.85K 股 · $24.58M · Q2 2026
- Nan Fung Group Holdings Ltd 2.30M 股 · $23.44M · Q3 2026
- Velan Capital Investment Management LP 492.89K 股 · $17.67M · Q2 2026
- Sanofi 912.04K 股 · $9.29M · Q3 2026
- DAFNA Capital Management LLC 171.01K 股 · $6.13M · Q2 2026
- Blue Owl Capital Holdings LP 556.37K 股 · $5.67M · Q3 2026
- SUPERSTRING CAPITAL MANAGEMENT LP 125.43K 股 · $4.50M · Q2 2026
- STEMPOINT CAPITAL LP 106.91K 股 · $3.83M · Q2 2026
更多关于 Pivotal bioVenture Partners Investment Advisor LLC
常见问题
How long has Pivotal bioVenture Partners Investment Advisor LLC held MPLT?
Pivotal bioVenture Partners Investment Advisor LLC has disclosed MPLT holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Pivotal bioVenture Partners Investment Advisor LLC's current position in MPLT?
As of Q3 2026, Pivotal bioVenture Partners Investment Advisor LLC holds 611.45K shares of MPLT (MAPLIGHT THERAPEUTICS INC), valued at $6.23M, representing 2.54% of its reported portfolio and ranking #11.
Has Pivotal bioVenture Partners Investment Advisor LLC been buying or selling MPLT?
In the latest 13F filing (Q3 2026), Pivotal bioVenture Partners Investment Advisor LLC held unchanged its position in MPLT. The position peaked in Q2 2026 at 611.45K shares.
Which other funds hold MPLT?
Other major institutional holders of MPLT include Novo Holdings A/S, FCPM III SERVICES B.V., 5AM Venture Management, LLC, among 97 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.